Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
D DERMATOLOGICALS
D01 ANTIFUNGALS FOR DERMATOLOGICAL USE
D01A ANTIFUNGALS FOR TOPICAL USE
D01AC Imidazole and triazole derivatives
D01AC19 Efinaconazole
D10021 Efinaconazole (JAN/USAN/INN) <JP/US>
USP drug classification [BR:br08302]
Dermatological Agents
Topical Anti-infectives
Antifungals, dermatological
Efinaconazole
D10021 Efinaconazole (JAN/USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
62 Chemotherapeutics
629 Miscellaneous
6290 Miscellaneous
D10021 Efinaconazole (JAN/USAN/INN)
Drug groups [BR:br08330]
Antifungal
DG01523 Triazole antifungal
D10021 Efinaconazole
Drug classes [BR:br08332]
Antifungal
DG01523 Triazole antifungal
D10021 Efinaconazole
Antimicrobials [BR:br08307]
Antifungals
Ergosterol biosynthesis inhibitor
Triazole
D10021 Efinaconazole (JAN/USAN/INN) <JP/US>
Antimicrobials abbreviations [BR:br08327]
Antifungals
Ergosterol biosynthesis inhibitor
Triazole
D10021 Efinaconazole (JAN/USAN/INN)
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D10021
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D10021
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D10021